Financial Data and Key Metrics Changes - The company reported Q1 revenue at $364.5 million, achieving the high end of its guidance range, despite a 3% negative foreign currency impact of $12.3 million [20] - GAAP earnings per share were $2.14, while adjusted earnings per share were $0.23, surpassing guidance and showing significant improvement over the prior year [20] - Q1 gross margin was 67.8%, down from 70.5% in the prior year, primarily due to revenue mix changes [20] - Selling expense as a percentage of revenue was 32.5%, a decline from the prior year, reflecting the overall revenue mix [21] - General and administrative expenses improved to 28.9% from 29.9%, indicating cost reduction efforts [22] Business Line Data and Key Metrics Changes - The core Nu Skin business gross margin was 76.7%, slightly down from the prior year but showing sequential improvement [20] - The RISE segments experienced 10% year-over-year growth in manufacturing, indicating strong performance in this area [7] - Latin America saw significant growth with a 144% year-on-year increase, driven by a focused developing market strategy [11] Market Data and Key Metrics Changes - Improving trends were noted in South Korea and China, while Europe and Africa showed better results due to an enhanced sales performance plan [6] - Southeast Asia Pacific markets experienced growth, although Indonesia faced additional headwinds [7] - Japan's performance remained stable on a local currency basis, contributing to a consistent consumer base [7] Company Strategy and Development Direction - The company outlined three strategic priorities for 2025: strengthening the core Nu Skin business, accelerating innovation with the IO intelligent beauty and wellness platform, and improving operational performance [8][9] - A major milestone was achieved with over $20 billion in sales compensation paid to the sales force, emphasizing the commitment to rewarding brand affiliates [10] - The company plans to enter the Indian market in mid-2026, leveraging a localized product suite and compensation plan [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's future despite macroeconomic pressures, highlighting strong partnerships with sales leaders [5] - The company is implementing proactive supply chain strategies to mitigate risks from global uncertainties, including tariffs [25] - Current projections suggest that tariffs are unlikely to materially impact costs in the near term, but consumer sentiment will be closely monitored [25] Other Important Information - The company reduced outstanding debt by $155 million, achieving the lowest debt level in over ten years [24] - Approximately $8 million was returned to shareholders through dividends and share repurchases [24] - The launch of the Prism IO intelligent wellness platform is anticipated to enhance customer relationships and drive revenue growth [13][17] Q&A Session Summary Question: What are the expectations for revenue in Q2? - The company projects second quarter revenue between $355 million and $390 million, factoring in an expected foreign currency headwind of 2% to 3% [26] Question: How is the company addressing macroeconomic pressures? - The company is implementing proactive supply chain strategies and closely monitoring potential effects on consumer sentiment and demand [25]

Financial Data and Key Metrics Changes - The company reported Q1 revenue of $364.5 million, achieving the high end of its guidance range, despite a 3% negative foreign currency impact of $12.3 million [17] - GAAP earnings per share (EPS) was $2.14, while adjusted EPS was $0.23, surpassing guidance and showing significant improvement over the prior year [17] - Q1 gross margin was 67.8%, down from 70.5% in the prior year, primarily due to revenue mix changes [17] - Selling expenses as a percentage of revenue decreased to 32.5%, reflecting a decline from the prior year [18] - General and administrative expenses improved to 28.9% of revenue, down from 29.9% [19] - The company reduced outstanding debt by $155 million, bringing total debt to $239 million, the lowest level in over ten years [21] Business Line Data and Key Metrics Changes - Significant growth was noted in Latin America, with a year-on-year growth of 144%, driven by a developing market strategy [5][9] - The core Nu Skin business gross margin was 76.7%, slightly down from the prior year but showing sequential improvement [17] - The RISE segments experienced 10% year-over-year growth in manufacturing [6] Market Data and Key Metrics Changes - Improving trends in key performance indicators (KPIs) were observed in South Korea and China, while Europe and Africa showed better results due to an enhanced sales performance plan [6] - Southeast Asia Pacific markets showed growth, although Indonesia faced additional headwinds [6] Company Strategy and Development Direction - The company outlined three strategic priorities for 2025: strengthening the core Nu Skin business, accelerating innovation related to the IO intelligent beauty and wellness platform, and improving operational performance and efficiency [7] - A major milestone was achieved with over $20 billion in sales compensation paid to the sales force, emphasizing the commitment to enhancing the sales compensation plan [8] - The company plans to enter the Indian market in Q4 2025, targeting a population of 1.4 billion with locally manufactured products [10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's future despite near-term macroeconomic pressures, highlighting strong partnerships with sales leaders [4] - The company is implementing proactive supply chain strategies to mitigate risks from global uncertainties, including tariffs [22] - Guidance for Q2 revenue is projected between $355 million and $390 million, with anticipated foreign currency headwinds of 2% to 3% [23] Other Important Information - The introduction of Prism IO, an intelligent wellness platform, is expected to enhance customer relationships and product recommendations [11] - The company has amassed a significant antioxidant database, which will support the development of customized nutrition solutions [12][14] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Performance - Q1 2025 revenue was $364.5 million, a decrease of 12.7% year-over-year, with a foreign exchange impact of $(12.3) million or (3.0)%[3] - Total revenue for Q1 2025 was $364.49 million, a decrease of 12.6% compared to $417.31 million in Q1 2024[20] - For Q2 2025, revenue is projected to be between $355 million and $390 million, reflecting a decline of 19% to 11% year-over-year[6] - Full-year 2025 revenue guidance is set at $1.48 to $1.62 billion, representing a decrease of 15% to 6% compared to 2024[6] - The overall Revenue Growth Rate for 2024 is expected to decline between (19)% and (11)%[36] - Adjusted 2024 Revenue is projected at $427,074,000, reflecting a revenue growth rate of (17)% to (9)% excluding Mavely[36] - Forecasted 2025 Revenue ranges from $1,480,000,000 to $1,620,000,000, indicating a potential recovery in growth rates[36] - The company anticipates a significant improvement in revenue performance in 2025 compared to 2024[36] Customer Metrics - Total customers decreased by 11% to 776,712, while paid affiliates and sales leaders decreased by 15% and 20%, respectively[3] - Total customers decreased by 11% year-over-year to 776,712, with significant declines in Southeast Asia/Pacific (20%) and Mainland China (25%)[18] - Total paid affiliates decreased by 15% to 131,518, with the largest drop in Southeast Asia/Pacific (25%) and Mainland China (19%)[18] - Total sales leaders decreased by 20% to 31,036, with the most significant decline in Mainland China (35%) and South Korea (31%)[18] Earnings and Profitability - Earnings per share (EPS) for Q1 2025 was $2.14, or $0.23 excluding the gain from the Mavely sale and other charges, compared to $(0.01) or $0.09 in the prior year[4] - Net income for Q1 2025 was $107.52 million, compared to a net loss of $0.53 million in Q1 2024[20] - Operating loss for Q1 2025 was $9.90 million, while adjusted operating income was $23.18 million, reflecting a margin of 6.4% excluding certain charges[27] - The diluted earnings per share for Q1 2025 was $2.14, compared to a loss of $0.01 per share in Q1 2024[20] Expenses and Debt Management - Gross margin for Q1 2025 was 67.8%, down from 70.5% in the prior year, with selling expenses reduced to 32.5% from 36.8%[4] - General and administrative expenses were $113.20 million, representing 31.1% of revenue, an increase from 29.9% in Q1 2024[25] - The company reduced outstanding debt by $155 million, achieving its lowest debt level in over 10 years[7] Strategic Initiatives - The company plans to launch the Prysm iO intelligent wellness device in the second half of 2025, aimed at enhancing customer satisfaction and loyalty[3] - The company is preparing for market expansion into India, with a pre-opening planned for Q4 2025 and a formal launch in mid-2026[3] - Dividend payments totaled $3.0 million, with an additional $5.0 million allocated for stock repurchases, leaving $157.4 million remaining in authorization[5] Market Outlook and Strategy - The financial outlook suggests a strategic focus on enhancing revenue streams while managing the impact of Mavely[36] - The company is actively monitoring market conditions to adjust forecasts and strategies accordingly[36] - Future growth strategies may include new product developments and market expansions to drive revenue recovery[36]

Industry Overview - The beauty and cosmetics industry has evolved from natural ingredients to advanced, science-backed formulations, becoming a multi-billion-dollar powerhouse that shapes self-expression and personal identity [1] - There is a significant shift towards skincare over traditional makeup, with consumers prioritizing healthy skin and demanding products with natural ingredients and clean formulations [2] Sustainability Trends - Sustainability is a defining factor in modern cosmetics, with consumers favoring brands that prioritize transparency and ethical sourcing [3] - Companies like e.l.f. Beauty, Inc. have successfully blended affordability with cruelty-free and vegan formulations, positioning themselves for long-term success as regulatory bodies push for clearer labeling [3] Technological Advancements - Technology is revolutionizing the beauty industry through AI-powered diagnostics, AR-driven virtual try-ons, and biotech formulations, making beauty more personalized and effective [4] - The rise of dermocosmetics, where beauty meets pharmaceutical-grade skincare, has led to the success of brands backed by dermatological research [4] Market Growth Projections - The global cosmetics market is expected to witness a CAGR of approximately 6.1% from 2024 to 2030, with companies focusing on innovation, sustainability, and digital engagement poised for success [5] Company Highlights: Nu Skin Enterprises, Inc. - Nu Skin is at the forefront of innovation, leveraging advanced technology and scientific breakthroughs to redefine beauty, with a focus on premium skincare innovations [6] - The company has developed a database of over 25 million connected treatments and is preparing to launch Prysm iO, a device for measuring micronutrient absorption in the skin [7] - Nu Skin's integration of AI-driven data analysis with skincare offerings enhances customer experiences and market penetration [8] Company Highlights: Ulta Beauty, Inc. - Ulta Beauty strengthens its position through innovation, exclusive brand partnerships, and advanced digital engagement, introducing new brands and collaborations [9] - The company boasts a loyalty program with 44.4 million active members, driving customer engagement and retention [10] - Ulta's digital and omnichannel strategy includes features like the GLAMlab 2.0 virtual try-on tool, enhancing the shopping experience [10][11] Company Highlights: Sally Beauty Holdings, Inc. - Sally Beauty focuses on product innovation, omnichannel expansion, and customer engagement, with a recent store refresh receiving positive customer feedback [12] - The company is experiencing significant e-commerce growth through partnerships with DoorDash and Instacart, supported by proprietary hair color and care products [12] - Sally Beauty is expanding its distribution of premium haircare brands and introducing new products in collaboration with Sauce Beauty [13][14]

Group 1 - Nu Skin Enterprises (NUS) is currently outperforming its Consumer Staples peers with a year-to-date return of 11%, compared to the sector average of 4.9% [4] - The Zacks Rank for Nu Skin Enterprises is 1 (Strong Buy), indicating a strong potential for outperformance in the market [3] - The Zacks Consensus Estimate for NUS's full-year earnings has increased by 7.1% over the past quarter, reflecting improved analyst sentiment [4] Group 2 - Nu Skin Enterprises is part of the Cosmetics industry, which has seen an average loss of 8.8% year-to-date, further highlighting NUS's strong performance in this context [6] - The Consumer Staples group, which includes 180 companies, is currently ranked 10 within the Zacks Sector Rank [2] - Primo Brands (PRMB), another stock in the Consumer Staples sector, has also outperformed with a return of 13.1% year-to-date [5]

Revenue Performance - In 2024, the company generated revenue of $1.7 billion, with 30% coming from the United States and 70% from international markets[13][15]. - Total revenue for Nu Skin in 2024 was $1,445.5 million, a decrease of 17.5% from $1,752.5 million in 2023[63]. - Revenue from the Americas segment was $322.5 million in 2024, representing a 19% decline from $398.2 million in 2023[63]. - Revenue from Southeast Asia/Pacific was $244.8 million in 2024, down 8.4% from $267.2 million in 2023[63]. - Revenue from Mainland China decreased to $235.2 million in 2024, a 21.1% drop from $298.1 million in 2023[63]. - The Rhyz business segment generated $286.6 million in total revenue in 2024, up 32.3% from $216.6 million in 2023[63]. - Manufacturing revenue increased to $201.4 million in 2024, a 11.0% increase from $181.4 million in 2023[63]. Product Categories - Revenue from beauty products was $681.8 million (39.4% of total revenue), while wellness products generated $757.2 million (43.7% of total revenue) in 2024[24]. - The ageLOC beauty products accounted for 43% of the beauty product category revenue and 17% of total revenue in 2024[24]. - The ageLOC TRMe personalized weight wellness line became the top-selling brand in 2024, with ageLOC wellness products making up 20% of total revenue[19][25]. Customer and Affiliate Metrics - Total Customers decreased from 1,147,124 in 2022 to 831,972 in 2024, representing a decline of approximately 27.5%[45]. - Total Paid Affiliates decreased from 236,956 in 2022 to 144,874 in 2024, a decline of about 38.8%[45]. - Total Sales Leaders decreased from 48,737 in 2022 to 36,912 in 2024, reflecting a decrease of approximately 24.3%[45]. Digital Transformation and Innovation - The company is undergoing a significant digital transformation, which will require substantial expenditures over the next several years[35]. - The company is developing new digital tools and enhanced e-commerce functionality to support its sales force and improve consumer engagement[34]. - The company launched ageLOC WellSpa iO and Nu Skin RenuSpa iO connected devices, which gather consumer behavior data for personalized experiences[18]. Regulatory Environment - Regulatory scrutiny in Mainland China has increased since 2019, impacting business operations and revenue potential[66]. - Direct selling regulations in Mainland China limit compensation to a maximum of 30% of revenue generated by sales[68]. - The FDA's implementation of the Modernization of Cosmetics Regulation Act of 2022 may impose additional compliance burdens on cosmetic manufacturers[73]. - The regulatory environment for dietary supplements is becoming increasingly complex, with stricter regulations anticipated in the future[88]. Supply Chain and Manufacturing Risks - The company experienced production difficulties and quality control problems that could lead to stock outages or shortages in the market[206]. - The company faces risks related to supply chain disruptions, including potential loss of suppliers and difficulties in sourcing alternative materials, which could harm revenue[208]. - The COVID-19 pandemic has caused significant disruptions in global transportation channels, resulting in delays, quantity limits, and price increases[210]. Sales Force and Compensation - The company’s global sales compensation plan is considered one of the most generous in the direct selling industry, providing competitive advantages[50]. - The company’s sales force is primarily composed of independent contractors who are required to adhere to ethical standards and consumer protection policies[38]. - The company’s sales leaders in Mainland China are compensated under a separate model, which is competitive but distinct from the global compensation plan[181]. Challenges and Competition - The company faces significant risks associated with direct selling, including regulatory scrutiny and potential legal actions that could impact revenue and profitability[143]. - The company is challenged by shifting consumer preferences and increased competition from affiliate marketing and gig economy businesses[160]. - The company faces intense competition, with competitors having greater name recognition and financial resources, which may hinder market share[167]. Employee and Human Capital Management - The company had approximately 3,100 full- and part-time employees worldwide as of December 31, 2024, excluding about 8,200 sales employees in Mainland China[109]. - The company’s human capital management strategy includes hiring, engagement, development, and retention initiatives to address competition for qualified employees[110]. - The company’s employee wellness program, "The Best You," aims to enhance physical, emotional, intellectual, and financial wellness[117].

Core Insights - Nu Skin Enterprises, Inc. (NUS) reported fourth-quarter 2024 results with earnings surpassing estimates, while net sales declined year over year [1][2] - The company anticipates improving trends in several markets for 2025 but expects economic challenges in Greater China and South Korea [1] Financial Performance - Adjusted earnings for Q4 were 38 cents per share, up from 37 cents in the previous year, beating the Zacks Consensus Estimate of 22 cents [2] - Quarterly revenues were $445.6 million, down 8.8% year over year, with a negative impact of 4.1% from foreign currency fluctuations; on a constant-currency basis, revenues fell 4.7% [3] - Adjusted gross profit decreased 9.8% to $317.9 million, with an adjusted gross margin of 71.4%, down 70 basis points from the prior year [5] - Selling expenses declined 8.8% to $165.4 million, remaining flat as a percentage of revenues at 37.1% [6] - General and administrative expenses fell 16.6% to $120.9 million, with a percentage of revenues at 27.1%, down 260 basis points [7] - Adjusted operating income increased 10.1% year over year to $34.5 million, with an adjusted operating margin of 7.7%, up 130 basis points [7] Regional Performance - Revenue declines were noted across various regions: Americas (-12.7%), Southeast Asia/Pacific (-2.9%), Mainland China (-21.1%), Japan (-6.8%), South Korea (-30.9%), Europe and Africa (-11%), and Hong Kong/Taiwan (-21%); however, other revenues surged 66.8% year over year [8] Financial Health - At the end of the quarter, the company had cash and cash equivalents of $186.9 million, long-term debt of $363.6 million, and total stockholders' equity of $651.5 million [9] - The company declared a cash dividend of 6 cents per share, payable on March 5, 2025 [10] Future Outlook - For 2025, Nu Skin anticipates revenues between $1.48 billion and $1.62 billion, indicating a decline of 15-6% from the previous year [12] - EPS for 2025 is projected to be between $3.45 and $3.85, or 90 cents to $1.30 when excluding gains from the Mavely transaction [13] - For Q1 2025, revenues are expected to be between $345 million and $365 million, representing a decline of 17% to 13% [13]

Financial Data and Key Metrics Changes - Fourth quarter revenue reached $445.6 million, exceeding previous guidance despite a 4% negative foreign currency impact of $20.1 million [33] - Adjusted earnings per share for Q4 was $0.38, surpassing guidance and slightly ahead of the prior year's $0.37 [34] - Full year revenue totaled $1.73 billion, within original guidance despite an unexpected foreign exchange headwind of approximately $60 million [34] - Adjusted gross margin for Q4 was 71.4%, down from 72.1% in the prior year, while the core Nu Skin business adjusted gross margin was 76.6%, down from 77.4% [34] Business Line Data and Key Metrics Changes - The launch of the AgeLock TrueFase peptide retinol complex contributed to Q4 results, with the new TrueFace product showing strong market acceptance [12][13] - The RISE segment achieved 28% year-on-year growth in Q4, indicating strong performance in this area [13] - A $38.8 million write-down was recorded this quarter as part of a strategy to streamline the product portfolio [35] Market Data and Key Metrics Changes - Growth was noted in Latin America and parts of Southeast Asia, while persistent headwinds remained in China and South Korea [11] - The Americas segment showed constant currency growth, with particular strength in Latin America [11] - The company anticipates revenue declines of 3% to 11% for 2025, excluding the impact of the Mable business from the prior year [44] Company Strategy and Development Direction - The company aims to strengthen its core Nu Skin business, accelerate innovation in its intelligent beauty and wellness platform, and improve operational performance and efficiency [15] - A new business model is being rolled out to enhance the entrepreneurial model for affiliates, focusing on social-first selling [18] - The company plans to refine its product portfolio to meet emerging consumer needs and increase focus on developing markets [19] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing economic challenges in South Korea and China, with consumer spending dropping and savings rates increasing [51] - The company is optimistic about growth opportunities in Latin America, Southeast Asia, and Japan for 2025 [60][61] - The management expressed confidence in achieving meaningful earnings growth despite top-line pressures in certain markets [46] Other Important Information - The strategic transaction involving the sale of the Mable business for $250 million was highlighted, which generated a five times return on investment [14] - The company has made significant progress in strengthening its balance sheet, reducing debt by $110 million funded through cash from operations [41] - The restructuring plan is now materially complete, positioning the company for a more sustainable future [39] Q&A Session Summary Question: Economic challenges in South Korea and China - Management acknowledged ongoing economic challenges in these regions, with consumer spending dropping and local brands gaining priority [50][52] Question: Markets expected to return to growth in 2025 - Management highlighted Latin America, Southeast Asia, and Japan as key markets with potential for growth in 2025 [60][61] Question: Performance on Amazon - Management discussed the importance of maintaining brand image on Amazon and noted that the strategy has been beneficial in minimizing discount reselling [66][70]

Group 1: Earnings Performance - Nu Skin Enterprises reported quarterly earnings of $0.38 per share, exceeding the Zacks Consensus Estimate of $0.22 per share, and showing a slight increase from $0.37 per share a year ago [1] - The earnings surprise for the quarter was 72.73%, compared to a previous quarter where the company reported earnings of $0.17 per share against an expectation of $0.20, resulting in a surprise of -15% [2] - Over the last four quarters, the company has surpassed consensus EPS estimates three times [2] Group 2: Revenue Performance - The company posted revenues of $445.55 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.01%, but down from $488.64 million year-over-year [3] - Nu Skin has topped consensus revenue estimates two times over the last four quarters [3] Group 3: Stock Performance and Outlook - Nu Skin shares have declined approximately 8.3% since the beginning of the year, while the S&P 500 has gained 2.9% [4] - The current consensus EPS estimate for the upcoming quarter is $0.27 on revenues of $433.9 million, and for the current fiscal year, it is $0.76 on revenues of $1.8 billion [8] - The Zacks Industry Rank indicates that the Cosmetics industry is currently in the bottom 32% of over 250 Zacks industries, suggesting potential underperformance compared to higher-ranked industries [9] Group 4: Estimate Revisions and Ratings - Ahead of the earnings release, the estimate revisions trend for Nu Skin was unfavorable, resulting in a Zacks Rank 5 (Strong Sell) for the stock, indicating expected underperformance in the near future [7] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]

Financial Results Announcement - Nu Skin Enterprises announced preliminary financial results for the three-month period ended December 31, 2024 [4] - The press release containing the financial results is attached as Exhibit 99.1 to the report [4] Regulatory and Filing Information - The information provided is not deemed "filed" under the Securities Exchange Act of 1934 and will not be incorporated by reference in any filings unless specifically referenced [5] - The report includes an Interactive Data File (Inline XBRL) as part of the exhibits [6] Executive Signatory - James D. Thomas, Chief Financial Officer, signed the report on behalf of Nu Skin Enterprises, Inc. [8]